The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Therapeutics Market Research Report 2025
Synopsis
The global Pet Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 31%.
This report aims to provide a comprehensive presentation of the global market for Pet Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Therapeutics.
Report Scope
The Pet Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals
Eli Lilly and Company
Merck
Vetoquinol
Zoetis
Segment by Type
Infectious Diseases
Dermatological Diseases
Orthopedic Diseases
Behavioral Disorders
Others
Segment by Application
Dogs
Cats
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pet Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 31%.
This report aims to provide a comprehensive presentation of the global market for Pet Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Therapeutics.
Report Scope
The Pet Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals
Eli Lilly and Company
Merck
Vetoquinol
Zoetis
Segment by Type
Infectious Diseases
Dermatological Diseases
Orthopedic Diseases
Behavioral Disorders
Others
Segment by Application
Dogs
Cats
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infectious Diseases
1.2.3 Dermatological Diseases
1.2.4 Orthopedic Diseases
1.2.5 Behavioral Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pet Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Therapeutics Market Perspective (2019-2030)
2.2 Pet Therapeutics Growth Trends by Region
2.2.1 Global Pet Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pet Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Pet Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Pet Therapeutics Market Dynamics
2.3.1 Pet Therapeutics Industry Trends
2.3.2 Pet Therapeutics Market Drivers
2.3.3 Pet Therapeutics Market Challenges
2.3.4 Pet Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Therapeutics Players by Revenue
3.1.1 Global Top Pet Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Pet Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Pet Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Therapeutics Revenue
3.4 Global Pet Therapeutics Market Concentration Ratio
3.4.1 Global Pet Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Therapeutics Revenue in 2023
3.5 Pet Therapeutics Key Players Head office and Area Served
3.6 Key Players Pet Therapeutics Product Solution and Service
3.7 Date of Enter into Pet Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Therapeutics Breakdown Data by Type
4.1 Global Pet Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Pet Therapeutics Forecasted Market Size by Type (2025-2030)
5 Pet Therapeutics Breakdown Data by Application
5.1 Global Pet Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Pet Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pet Therapeutics Market Size (2019-2030)
6.2 North America Pet Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pet Therapeutics Market Size by Country (2019-2024)
6.4 North America Pet Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Therapeutics Market Size (2019-2030)
7.2 Europe Pet Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pet Therapeutics Market Size by Country (2019-2024)
7.4 Europe Pet Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Pet Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pet Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Pet Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Therapeutics Market Size (2019-2030)
9.2 Latin America Pet Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pet Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Pet Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Pet Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pet Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Pet Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Detail
11.1.2 Elanco Business Overview
11.1.3 Elanco Pet Therapeutics Introduction
11.1.4 Elanco Revenue in Pet Therapeutics Business (2019-2024)
11.1.5 Elanco Recent Development
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Company Detail
11.2.2 Boehringer Ingelheim GmbH Business Overview
11.2.3 Boehringer Ingelheim GmbH Pet Therapeutics Introduction
11.2.4 Boehringer Ingelheim GmbH Revenue in Pet Therapeutics Business (2019-2024)
11.2.5 Boehringer Ingelheim GmbH Recent Development
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Detail
11.3.2 Ceva Sante Animale Business Overview
11.3.3 Ceva Sante Animale Pet Therapeutics Introduction
11.3.4 Ceva Sante Animale Revenue in Pet Therapeutics Business (2019-2024)
11.3.5 Ceva Sante Animale Recent Development
11.4 Dechra Pharmaceuticals
11.4.1 Dechra Pharmaceuticals Company Detail
11.4.2 Dechra Pharmaceuticals Business Overview
11.4.3 Dechra Pharmaceuticals Pet Therapeutics Introduction
11.4.4 Dechra Pharmaceuticals Revenue in Pet Therapeutics Business (2019-2024)
11.4.5 Dechra Pharmaceuticals Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Detail
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Pet Therapeutics Introduction
11.5.4 Eli Lilly and Company Revenue in Pet Therapeutics Business (2019-2024)
11.5.5 Eli Lilly and Company Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Pet Therapeutics Introduction
11.6.4 Merck Revenue in Pet Therapeutics Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Vetoquinol
11.7.1 Vetoquinol Company Detail
11.7.2 Vetoquinol Business Overview
11.7.3 Vetoquinol Pet Therapeutics Introduction
11.7.4 Vetoquinol Revenue in Pet Therapeutics Business (2019-2024)
11.7.5 Vetoquinol Recent Development
11.8 Zoetis
11.8.1 Zoetis Company Detail
11.8.2 Zoetis Business Overview
11.8.3 Zoetis Pet Therapeutics Introduction
11.8.4 Zoetis Revenue in Pet Therapeutics Business (2019-2024)
11.8.5 Zoetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pet Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Infectious Diseases
Table 3. Key Players of Dermatological Diseases
Table 4. Key Players of Orthopedic Diseases
Table 5. Key Players of Behavioral Disorders
Table 6. Key Players of Others
Table 7. Global Pet Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Pet Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Pet Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Pet Therapeutics Market Share by Region (2019-2024)
Table 11. Global Pet Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Pet Therapeutics Market Share by Region (2025-2030)
Table 13. Pet Therapeutics Market Trends
Table 14. Pet Therapeutics Market Drivers
Table 15. Pet Therapeutics Market Challenges
Table 16. Pet Therapeutics Market Restraints
Table 17. Global Pet Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Pet Therapeutics Market Share by Players (2019-2024)
Table 19. Global Top Pet Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Therapeutics as of 2023)
Table 20. Ranking of Global Top Pet Therapeutics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Pet Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pet Therapeutics Product Solution and Service
Table 24. Date of Enter into Pet Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pet Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Pet Therapeutics Revenue Market Share by Type (2019-2024)
Table 28. Global Pet Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Pet Therapeutics Revenue Market Share by Type (2025-2030)
Table 30. Global Pet Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Pet Therapeutics Revenue Market Share by Application (2019-2024)
Table 32. Global Pet Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Pet Therapeutics Revenue Market Share by Application (2025-2030)
Table 34. North America Pet Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Pet Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Pet Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Pet Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Pet Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Pet Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Pet Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Pet Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Pet Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Pet Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Pet Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Pet Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Pet Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Pet Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Pet Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 49. Elanco Company Detail
Table 50. Elanco Business Overview
Table 51. Elanco Pet Therapeutics Product
Table 52. Elanco Revenue in Pet Therapeutics Business (2019-2024) & (US$ Million)
Table 53. Elanco Recent Development
Table 54. Boehringer Ingelheim GmbH Company Detail
Table 55. Boehringer Ingelheim GmbH Business Overview
Table 56. Boehringer Ingelheim GmbH Pet Therapeutics Product
Table 57. Boehringer Ingelheim GmbH Revenue in Pet Therapeutics Business (2019-2024) & (US$ Million)
Table 58. Boehringer Ingelheim GmbH Recent Development
Table 59. Ceva Sante Animale Company Detail
Table 60. Ceva Sante Animale Business Overview
Table 61. Ceva Sante Animale Pet Therapeutics Product
Table 62. Ceva Sante Animale Revenue in Pet Therapeutics Business (2019-2024) & (US$ Million)
Table 63. Ceva Sante Animale Recent Development
Table 64. Dechra Pharmaceuticals Company Detail
Table 65. Dechra Pharmaceuticals Business Overview
Table 66. Dechra Pharmaceuticals Pet Therapeutics Product
Table 67. Dechra Pharmaceuticals Revenue in Pet Therapeutics Business (2019-2024) & (US$ Million)
Table 68. Dechra Pharmaceuticals Recent Development
Table 69. Eli Lilly and Company Company Detail
Table 70. Eli Lilly and Company Business Overview
Table 71. Eli Lilly and Company Pet Therapeutics Product
Table 72. Eli Lilly and Company Revenue in Pet Therapeutics Business (2019-2024) & (US$ Million)
Table 73. Eli Lilly and Company Recent Development
Table 74. Merck Company Detail
Table 75. Merck Business Overview
Table 76. Merck Pet Therapeutics Product
Table 77. Merck Revenue in Pet Therapeutics Business (2019-2024) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Vetoquinol Company Detail
Table 80. Vetoquinol Business Overview
Table 81. Vetoquinol Pet Therapeutics Product
Table 82. Vetoquinol Revenue in Pet Therapeutics Business (2019-2024) & (US$ Million)
Table 83. Vetoquinol Recent Development
Table 84. Zoetis Company Detail
Table 85. Zoetis Business Overview
Table 86. Zoetis Pet Therapeutics Product
Table 87. Zoetis Revenue in Pet Therapeutics Business (2019-2024) & (US$ Million)
Table 88. Zoetis Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pet Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Infectious Diseases Features
Figure 4. Dermatological Diseases Features
Figure 5. Orthopedic Diseases Features
Figure 6. Behavioral Disorders Features
Figure 7. Others Features
Figure 8. Global Pet Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Pet Therapeutics Market Share by Application: 2023 VS 2030
Figure 10. Dogs Case Studies
Figure 11. Cats Case Studies
Figure 12. Other Case Studies
Figure 13. Pet Therapeutics Report Years Considered
Figure 14. Global Pet Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Pet Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Pet Therapeutics Market Share by Region: 2023 VS 2030
Figure 17. Global Pet Therapeutics Market Share by Players in 2023
Figure 18. Global Top Pet Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Therapeutics as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Pet Therapeutics Revenue in 2023
Figure 20. North America Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Pet Therapeutics Market Share by Country (2019-2030)
Figure 22. United States Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Pet Therapeutics Market Share by Country (2019-2030)
Figure 26. Germany Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Pet Therapeutics Market Share by Region (2019-2030)
Figure 34. China Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Pet Therapeutics Market Share by Country (2019-2030)
Figure 42. Mexico Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Pet Therapeutics Market Share by Country (2019-2030)
Figure 46. Turkey Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Pet Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Elanco Revenue Growth Rate in Pet Therapeutics Business (2019-2024)
Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Pet Therapeutics Business (2019-2024)
Figure 50. Ceva Sante Animale Revenue Growth Rate in Pet Therapeutics Business (2019-2024)
Figure 51. Dechra Pharmaceuticals Revenue Growth Rate in Pet Therapeutics Business (2019-2024)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Pet Therapeutics Business (2019-2024)
Figure 53. Merck Revenue Growth Rate in Pet Therapeutics Business (2019-2024)
Figure 54. Vetoquinol Revenue Growth Rate in Pet Therapeutics Business (2019-2024)
Figure 55. Zoetis Revenue Growth Rate in Pet Therapeutics Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
